Sign In
Buy BLUE
$4.97
+0 (+0%)
At Close: Aug 29, 2025
Bluebird Bio shares are trading lower after the company announced a $400 million common stock offering.
11:19am, Monday, 18'th May 2020Bluebird Bio's stock falls after proposed public stock offering
11:08am, Monday, 18'th May 2020
Shares of Bluebird Bio Inc. fell 2.9% in premarket trading Monday, after the gene therapy company said it was proposing a public offering of $400 million worth of common stock. Based on Friday's stoc
bluebird bio Announces Proposed Public Offering of Common Stock
11:00am, Monday, 18'th May 2020
bluebird bio, Inc. (Nasdaq: BLUE) today announced that it has commenced an underwritten public offering of $400 million of its common stock. bluebird bio also intends to grant the underwriters a 30-da
bluebird (BLUE): Strong Industry, Solid Earnings Estimate Revisions
01:01pm, Friday, 15'th May 2020
bluebird (BLUE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
bluebird bio To Present Data From Gene, Cell Therapy Programs At European Hematology Association Annual Congress On Jun. 12
01:11pm, Thursday, 14'th May 2020
bluebird bio to present data from its gene and cell therapy programs during virtual European Hematology Association Annual Congress.
BMS & bluebird bio to Present Updated Positive Results from Pivotal KarMMa Study of Ide-cel in Relapsed and Refractory Multiple Myeloma Patients
Bristol-Myers, Bluebird Bio to Resubmit FDA Bid for Myeloma Treatment
02:41pm, Wednesday, 13'th May 2020
Bristol-Myers Squibb and Bluebird Bio say the FDA declined to move forward on the application for their experimental multiple myeloma treatment.
20 Healthcare Stocks Moving In Wednesday's Pre-Market Session
11:33am, Wednesday, 13'th May 2020
BMS and bluebird bio Provide Regulatory Update on Idecabtagene Vicleucel (ide-cel, bb2121) for the Treatment of Patients with Multiple Myeloma
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
U.S. RESEARCH ROUNDUP-Digital Realty Trust, Pilgrims Pride, Terraform Power
07:26am, Tuesday, 12'th May 2020
Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including Digital Realty Trust, Pilgrims Pride and Terraform Power,
on Tuesday.
HIGH
